title: Effective treatment of migraine. Terminating acute attacks, reducing their frequency.
abstract: Migraine is the headache most commonly encountered in primary care practice. In one US population survey, 17.6% of women and 6% of men reported migraine. Specific, effective treatment options for migraine are increasingly available, helping to reinforce how important it is that this common and sometimes disabling condition be recognized by primary care physicians.
authors.affiliation: University of Toronto, Faculty of Medicine.
authors.forename: Tamara
authors.initials: T
authors.lastname: Pringsheim
authors.forename: John
authors.initials: J
authors.lastname: Edmeads
mesh_terms: D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D003937:Diagnosis, Differential; D006801:Humans; D015994:Incidence; D008881:Migraine Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D010358:Patient Participation; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods* / Q000592:standards; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors; D017366:Serotonin Receptor Agonists / Q000737:chemistry / Q000627:therapeutic use; D018170:Sumatriptan / Q000737:chemistry / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D014662:Vasoconstrictor Agents / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D002121:Calcium Channel Blockers; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D018170:Sumatriptan